» Articles » PMID: 26934296

Cleavage of Type I Collagen by Fibroblast Activation Protein-α Enhances Class A Scavenger Receptor Mediated Macrophage Adhesion

Overview
Journal PLoS One
Date 2016 Mar 3
PMID 26934296
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Pathophysiological conditions such as fibrosis, inflammation, and tumor progression are associated with modification of the extracellular matrix (ECM). These modifications create ligands that differentially interact with cells to promote responses that drive pathological processes. Within the tumor stroma, fibroblasts are activated and increase the expression of type I collagen. In addition, activated fibroblasts specifically express fibroblast activation protein-α (FAP), a post-prolyl peptidase. Although FAP reportedly cleaves type I collagen and contributes to tumor progression, the specific pathophysiologic role of FAP is not clear. In this study, the possibility that FAP-mediated cleavage of type I collagen modulates macrophage interaction with collagen was examined using macrophage adhesion assays. Our results demonstrate that FAP selectively cleaves type I collagen resulting in increased macrophage adhesion. Increased macrophage adhesion to FAP-cleaved collagen was not affected by inhibiting integrin-mediated interactions, but was abolished in macrophages lacking the class A scavenger receptor (SR-A/CD204). Further, SR-A expressing macrophages localize with activated fibroblasts in breast tumors of MMTV-PyMT mice. Together, these results demonstrate that FAP-cleaved collagen is a substrate for SR-A-dependent macrophage adhesion, and suggest that by modifying the ECM, FAP plays a novel role in mediating communication between activated fibroblasts and macrophages.

Citing Articles

Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets.

Lv K, He T Mol Biomed. 2024; 5(1):70.

PMID: 39680287 PMC: 11649616. DOI: 10.1186/s43556-024-00233-8.


CAF-induced physical constraints controlling T cell state and localization in solid tumours.

Arpinati L, Carradori G, Scherz-Shouval R Nat Rev Cancer. 2024; 24(10):676-693.

PMID: 39251836 DOI: 10.1038/s41568-024-00740-4.


Tissue Mechanics and Hedgehog Signaling Crosstalk as a Key Epithelial-Stromal Interplay in Cancer Development.

Karunasagara S, Taghizadeh A, Kim S, Kim S, Kim Y, Taghizadeh M Adv Sci (Weinh). 2024; 11(35):e2400063.

PMID: 38976559 PMC: 11425211. DOI: 10.1002/advs.202400063.


Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.

Kundu M, Butti R, Panda V, Malhotra D, Das S, Mitra T Mol Cancer. 2024; 23(1):92.

PMID: 38715072 PMC: 11075356. DOI: 10.1186/s12943-024-01990-4.


Fibrillar extracellular matrix produced by pericyte-like cells facilitates glioma cell dissemination.

Vymola P, Garcia-Borja E, cervenka J, Balaziova E, Vymolova B, Veprkova J Brain Pathol. 2024; 34(6):e13265.

PMID: 38705944 PMC: 11483521. DOI: 10.1111/bpa.13265.


References
1.
Gordon S . Pattern recognition receptors: doubling up for the innate immune response. Cell. 2003; 111(7):927-30. DOI: 10.1016/s0092-8674(02)01201-1. View

2.
Kelly T, Huang Y, Simms A, Mazur A . Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int Rev Cell Mol Biol. 2012; 297:83-116. DOI: 10.1016/B978-0-12-394308-8.00003-0. View

3.
Zhang K, Chen J . The regulation of integrin function by divalent cations. Cell Adh Migr. 2012; 6(1):20-9. PMC: 3364134. DOI: 10.4161/cam.18702. View

4.
Lysko P, Weinstock J, Webb C, Brawner M, Elshourbagy N . Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. J Pharmacol Exp Ther. 1999; 289(3):1277-85. View

5.
Niedermeyer J, Scanlan M, Garin-Chesa P, Daiber C, Fiebig H, Old L . Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer. 1997; 71(3):383-9. DOI: 10.1002/(sici)1097-0215(19970502)71:3<383::aid-ijc14>3.0.co;2-h. View